Skip to main content

Table 4 Evaluation of mean visual acuity, mean central macular thickness and mean intraocular pressure between groups at 6 months after injection

From: Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema

 

AFL + AFL

RAN + RAN

AFL + DEX

RAN + DEX

P value

Average Visual Acuity LogMAR (6th month)

0.49 ± 0.22

0.57 ± 0.38

0.62 ± 0.38

0.80 ± 0.43

0.159

Central Macular Thickness (µm) (6th month)

291.6 ± 54.4

293.1 ± 79.5

320 ± 103.8

332.5 ± 96.8

0.295

Intraocular Pressure (mmHg) (6th month)

15.9 ± 3.5

15.59 ± 4

15.9 ± 3

18.1 ± 3.8

0.109